Literature DB >> 6146593

Lack of correlation between the presence of plasmids and fimbriae in Yersinia enterocolitica and Yersinia pseudotuberculosis.

M Skurnik.   

Abstract

Thirty-nine strains of Yersinia enterocolitica and 10 strains of Yersinia pseudotuberculosis were studied for the presence of fimbriae, plasmids and two plasmid associated phenotypic expressions, autoagglutination and Ca2+ dependent growth at 37 degrees C. All of the strains studied became fimbriated, which was confirmed by electron microscopy and haemagglutination tests. Fimbriation was not correlated with the presence or absence of plasmids.

Entities:  

Mesh:

Year:  1984        PMID: 6146593     DOI: 10.1111/j.1365-2672.1984.tb01362.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  36 in total

1.  Construction of urease-negative mutants of Yersinia enterocolitica serotypes O:3 and o:8: role of urease in virulence and arthritogenicity.

Authors:  C Gripenberg-Lerche; L Zhang; P Ahtonen; P Toivanen; M Skurnik
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Isolation of pathogenic Yersinia enterocolitica strains from different sources in Izmir region, Turkey.

Authors:  Elif Bozcal; Atac Uzel; Sohret Aydemir; Mikael Skurnik
Journal:  Folia Microbiol (Praha)       Date:  2015-04-26       Impact factor: 2.099

3.  Efficient insertion mutagenesis strategy for bacterial genomes involving electroporation of in vitro-assembled DNA transposition complexes of bacteriophage mu.

Authors:  Arja Lamberg; Sari Nieminen; Mingqiang Qiao; Harri Savilahti
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

4.  First analysis of a bacterial collagen-binding protein with collagen Toolkits: promiscuous binding of YadA to collagens may explain how YadA interferes with host processes.

Authors:  Jack C Leo; Heli Elovaara; Dominique Bihan; Nicholas Pugh; Sami K Kilpinen; Nicolas Raynal; Mikael Skurnik; Richard W Farndale; Adrian Goldman
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

5.  Characterization of the six glycosyltransferases involved in the biosynthesis of Yersinia enterocolitica serotype O:3 lipopolysaccharide outer core.

Authors:  Elise Pinta; Katarzyna Anna Duda; Anna Hanuszkiewicz; Tiina A Salminen; José Antonio Bengoechea; Heidi Hyytiäinen; Buko Lindner; Joanna Radziejewska-Lebrecht; Otto Holst; Mikael Skurnik
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

6.  Identification of the lipopolysaccharide core of Yersinia pestis and Yersinia pseudotuberculosis as the receptor for bacteriophage φA1122.

Authors:  Saija Kiljunen; Neeta Datta; Svetlana V Dentovskaya; Andrey P Anisimov; Yuriy A Knirel; José A Bengoechea; Otto Holst; Mikael Skurnik
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

7.  LcrF is the temperature-regulated activator of the yadA gene of Yersinia enterocolitica and Yersinia pseudotuberculosis.

Authors:  M Skurnik; P Toivanen
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

8.  Yersinia enterocolitica-Specific Infection by Bacteriophages TG1 and ϕR1-RT Is Dependent on Temperature-Regulated Expression of the Phage Host Receptor OmpF.

Authors:  Carlos G Leon-Velarde; Lotta Happonen; Maria Pajunen; Katarzyna Leskinen; Andrew M Kropinski; Laura Mattinen; Monika Rajtor; Joanna Zur; Darren Smith; Shu Chen; Ayesha Nawaz; Roger P Johnson; Joseph A Odumeru; Mansel W Griffiths; Mikael Skurnik
Journal:  Appl Environ Microbiol       Date:  2016-08-15       Impact factor: 4.792

9.  Functional mapping of YadA- and Ail-mediated binding of human factor H to Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Saara Salmenlinna; Markus Gruber; Andrei N Lupas; Seppo Meri; Mikael Skurnik
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Characterization of complement factor H binding to Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Hanna Jarva; Heidi Hyytiäinen; Seppo Meri; Mikael Skurnik
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.